PET-CT

PET-CT combines positron emission tomography (PET) detectors and computed tomography (CT) into one imaging system. 

FALCON Trial of Fluciclovine PET/CT Imaging Stops Recruitment after Successful Interim Analysis
News | Radiopharmaceuticals and Tracers | May 15, 2017

May 15, 2017 — Blue Earth Diagnostics announced that the Trial Steering Committee recommended further recruitment be...

PET/CT

The Philips Ingenuity TF PET/CT system leverages multiple technologies.

Feature | Radiation Oncology | May 05, 2017 | By Lola Koktysh

The continuum of personalized care, covering individualized prevention and therapy, translates into multiple changes...

PET/CT Helps Predict Therapy Effectiveness in Pediatric Brain Tumors

FIGURE: MRI AND PET-MRI FUSION IMAGES OF PATIENTS WITH DIPG. Top row: Zr-89-bevacizumab PET (144 hrs p.i.) fused with T1-Gd weighted MRI per patient; middle row: T1-Gd weighted MRI; lower row: T2-weighted/FLAIR MR-images. Five tumors show variable uptake of Zr-89-bevacizumab (white arrows), with both PET negative and positive areas within each tumor. Two primary tumors are completely PET negative (Fig. 1C and 1E), while the T2 weighted images show tumor infiltration in the whole pons of both patients. In the middle row, the red arrows represent the areas of contrast enhancement within the tumor. In four out of five primary tumors, the PET-positive area corresponds with the contrast-enhancing area on MRI of the tumors (Fig. 1A, 1B, 1F and 1G). In Fig. 1C, the tumor shows an MRI contrast-enhancing area, while there is no Zr-89-bevacizumab uptake. Fig. 1D shows a PET positive tumor, while no Gd-enhancement is observed on MRI. Credit: Sophie Veldhuijzen van Zanten and Marc Jansen, VU University Medical Center, Amsterdam, The Netherlands.

News | PET-CT | May 02, 2017

May 2, 2017 — In a first-ever molecular drug-imaging study in children, researchers in The Netherlands used whole-...

Videos | Nuclear Imaging | April 28, 2017

David Wolinsky, M.D., director of nuclear cardiology at Cleveland Clinic Florida and past-president of the American...

lung cancer recurrence, biomarker blood test, CT scans, 2017 Multidisciplinary Thoracic Cancers Symposium, clinical study
News | Lung Cancer | March 28, 2017

March 28, 2017 — Results from a prospective clinical trial showed a blood test looking at specific biomarkers was...

PET/CT, recurrent prostate cancer, fluciclovine F-18, Emory University

CTVPOST (red) = CTVPRE (yellow) union CTVPET (pink). Also shown (upper right corner) are the PRE (square) vs POST (triangle) dose volume histograms for PTV1, PTV2, rectum, bladder, and penile bulb, showing minimal impact on target coverage or organs at risk dose with the modified targets. Image courtesy of Ashesh B. Jani, M.D., and David Schuster, M.D., Emory University.

News | Radiopharmaceuticals and Tracers | March 16, 2017

March 16, 2017 — The featured clinical investigation article of the March 2017 issue of the ...

Medic Vision, 2016 growth, RSNA, dose management, reporting, SafeCT
News | Radiation Dose Management | November 10, 2016

November 10, 2016 — Medic Vision Imaging Solutions Ltd. announced recently that the company has tripled its growth....

PET/CT, atherosclerotic plaque detection, Stanford University

Application of dual-modality optical and PET/CT activity-based probe in experimental carotid inflammation model. Coronal noninvasive PET/CT scans of (A) healthy and (B) diseased mice with and without ligated carotid arteries respectively. Inset images show optical ex vivo florescence imagining of (A) healthy and (B) diseased carotid arteries.  PET/CT and optical images courtesy of Xiaowei Ma, Toshinobu Saito and Nimali Withana.

News | PET-CT | November 01, 2016

November 1, 2016 — Researchers at Stanford University have demonstrated for the first time the use of a dual optical...

Philips, RSNA 2016, IQon spectral CT

IQon Spectral CT image courtesy of Philips Healthcare

News | Information Technology | October 13, 2016

October 13, 2016 — Philips announced that it will be displaying a variety of solutions aimed at increasing...

radiology

Image courtesy of Pixabay

Blog | Radiology Imaging | October 12, 2016

We know where imaging has been.

We think it’s going to...

GE Healthcare, Discovery MI PET/CT system, FDA clearance, RSNA 2016
Technology | PET-CT | October 05, 2016

October 5, 2016 — GE Healthcare announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Discovery...

Celesteion PET/CT
News | PET-CT | October 03, 2016

October 1, 2016 — To advance clinical care for its customers, Toshiba’s Celesteion PET/CT system delivers a more...

patient centricity

Graphic courtesy of Pixabay

Blog | Radiology Imaging | September 07, 2016

Radiology cannot stay where it is. Yet threats make it dangerous to move. 

The adoption of...

PET/CT

There is a growing focus on early diagnosis and prevention. Here, PET/CT imaging is used to look inside the stress center of the brain.

Feature | Radiology Imaging | September 07, 2016 | By Kirill Shalyaev, Ph.D.

Advanced imaging and hybrid modalities, such as ...

PET, PET imaging, PET-CT, FDG PET, PET cancer assessment, nuclear imaging, molecular imaging

A PET-CT head and neck cancer scan showing various image reconstructions. The top left image is the separate CT scan showing the anatomy. The top right scan shows the fused PET and CT scans with false color added to help interpret the image. The bottom left scan is an initial FDG PET image showing tracer hot spots in the neck and a lymph node in the right jaw due to cancer. The right bottom image is a delayed enhancement scan showing tracer uptake over time, with normal hot spots in the bladder, kidneys, testicles and brain, which normally have higher metabolic activity. The low-grade gray shading of the anatomy is due to the normal cellular metabolism uptake of the FDG throughout the body. 

Feature | PET Imaging | July 26, 2016 | Dave Fornell

Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that...

imaging

Image courtesy of Pixabay.

Blog | Radiology Imaging | July 20, 2016

Making healthcare more objective and precise promises to increase efficiency and reduce costs — the key ingredients...

personalized medicine
Feature | Radiology Imaging | July 06, 2016 | Greg Freiherr

Mammography may be the most recognizable — and singularly effective — type of personalized medicine, benefitting...

PET-CT, advanced cancer, lean body mass, LBM, SNMMI 2016 study
News | Oncology Diagnostics | June 23, 2016

June 23, 2016 — Cancer patients often experience significant fluctuations in weight and lean body mass (LBM)....